用于预防旅行者腹泻的口服霍乱疫苗。
Oral cholera vaccine for traveler's diarrhea prophylaxis.
作者信息
Nickonchuk Tony, Lindblad Adrienne J, Kolber Michael R
机构信息
Pharmacy Manager in Peace River, Alta.
Knowledge Translation and Evidence Coordinator with the Alberta College of Family Physicians.
出版信息
Can Fam Physician. 2014 May;60(5):451.
Abstract
CLINICAL QUESTION
Should the oral cholera vaccine be routinely recommended to prevent traveler's diarrhea (TD)?
BOTTOM LINE
Randomized controlled trials evaluating oral cholera vaccine for TD did not show a benefit and routine use is not recommended.
摘要
临床问题
是否应常规推荐口服霍乱疫苗来预防旅行者腹泻（TD）？
结论
评估口服霍乱疫苗预防旅行者腹泻的随机对照试验未显示出益处，不建议常规使用。
相似文献
1
Oral cholera vaccine for traveler's diarrhea prophylaxis.
Can Fam Physician. 2014 May;60(5):451.
2
Effectiveness of the WC/rBS oral cholera vaccine in the prevention of traveler's diarrhea: a prospective cohort study.
Hum Vaccin Immunother. 2013 Mar;9(3):692-8. doi: 10.4161/hv.23267. Epub 2013 Jan 16.
3
Truth and direct-to-consumer advertising in Canada of DUKORAL for traveler's diarrhea prevention.
Can Fam Physician. 2019 Mar;65(3):171-173.
4
Prevention of fecal-orally transmitted diseases in travelers through an oral anticholeric vaccine (WC/rBS).
J Prev Med Hyg. 2012 Dec;53(4):199-203.
5
Traveler's Diarrhea.
Infect Dis Clin North Am. 2012 Sep;26(3):691-706. doi: 10.1016/j.idc.2012.06.002.
6
Prevention and treatment of traveler's diarrhea: a clinical pharmacological approach.
Chemotherapy. 1995;41 Suppl 1:48-81. doi: 10.1159/000239397.
7
Effectiveness and economic analysis of the whole cell/recombinant B subunit (WC/rbs) inactivated oral cholera vaccine in the prevention of traveller's diarrhoea.
BMC Infect Dis. 2009 May 16;9:65. doi: 10.1186/1471-2334-9-65.
8
Cholera vaccines.
Clin Infect Dis. 2000 Aug;31(2):561-5. doi: 10.1086/313951. Epub 2000 Sep 7.
9
Immunogenicity of cholera vaccination in children with inflammatory bowel disease.
Hum Vaccin Immunother. 2021 Aug 3;17(8):2586-2592. doi: 10.1080/21645515.2021.1884475. Epub 2021 Apr 1.
10
Oral cholera vaccine--for whom, when, and why?
Travel Med Infect Dis. 2006 Jan;4(1):38-42. doi: 10.1016/j.tmaid.2004.12.002.
本文引用的文献
1
Vaccines for preventing enterotoxigenic Escherichia coli (ETEC) diarrhoea.
Cochrane Database Syst Rev. 2013 Jul 5;2013(7):CD009029. doi: 10.1002/14651858.CD009029.pub2.
2
Loperamide plus azithromycin more effectively treats travelers' diarrhea in Mexico than azithromycin alone.
J Travel Med. 2007 Sep-Oct;14(5):312-9. doi: 10.1111/j.1708-8305.2007.00144.x.
3
Cholera: assessing the risk to travellers and identifying methods of protection.
Travel Med Infect Dis. 2003 May;1(2):80-8. doi: 10.1016/S1477-8939(03)00062-0.
4
The practice of travel medicine: guidelines by the Infectious Diseases Society of America.
Clin Infect Dis. 2006 Dec 15;43(12):1499-539. doi: 10.1086/508782. Epub 2006 Nov 8.
5
Oral cholera vaccines: use in clinical practice.
Lancet Infect Dis. 2006 Jun;6(6):361-73. doi: 10.1016/S1473-3099(06)70494-7.
6
Statement on new oral cholera and travellers' diarrhea vaccination.
Can Commun Dis Rep. 2005 Jul 1;31(ACS-7):1-11.
7
Traveller's diarrhoea.
Lancet Infect Dis. 2005 Jun;5(6):349-60. doi: 10.1016/S1473-3099(05)70139-0.
8
Enteroaggregative Escherichia coli as a major etiologic agent in traveler's diarrhea in 3 regions of the world.
Clin Infect Dis. 2001 Jun 15;32(12):1706-9. doi: 10.1086/320756. Epub 2001 May 21.
9
Antibiotic treatment for travellers' diarrhoea.
Cochrane Database Syst Rev. 2000;2000(3):CD002242. doi: 10.1002/14651858.CD002242.
10
Double-blind, randomized, placebo controlled pilot study evaluating efficacy and reactogenicity of an oral ETEC B-subunit-inactivated whole cell vaccine against travelers' diarrhea (preliminary report).
J Travel Med. 2000 Jan;7(1):27-9. doi: 10.2310/7060.2000.00007.
Zotero 插件